TP53 and colorectal carcinoma: The figure shows the anticancer activity of wogonin in colorectal cancer (CRC) HCT‐116 cells, indicating that the drug acts in dual ways, namely caspase‐dependent apoptosis and p53‐dependent endoplasmic reticulum (ER) stress.